Skip to main content
. 2021 Oct 18;11:753119. doi: 10.3389/fonc.2021.753119

Figure 2.

Figure 2

ARV-825 suppresses the viability of gastric cancer cells. (A) BET protein levels in gastric cancer cells. (B) Viability of gastric cancer cells treated with ARV-825 at different concentrations. Values of IC50 have been calculated and shown on the graph. (C) Chemical structures of ARV-825, OTX015, and JQ1. (D) The cell viability of MGC803, HGC27, AGS, and SGC7901 cells treated with ARV-825, OTX015, and JQ1. (E) Morphology of MGC803, HGC27, AGS, and SGC7901 cells treated with ARV-825.